Skip to main content
. 2021 Mar 4;2021(3):CD008726. doi: 10.1002/14651858.CD008726.pub3

Comparison 16. Carbapenems Ca vs cephalosporins C3 (3rd generation).

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
16.1 Maternal endometritis 1 48 Risk Ratio (M‐H, Fixed, 95% CI) 1.18 [0.08, 17.82]
16.2 Maternal fever (febrile morbidity) 1 48 Risk Ratio (M‐H, Fixed, 95% CI) 0.59 [0.06, 6.09]
16.3 Maternal wound infection 1 48 Risk Ratio (M‐H, Fixed, 95% CI) 0.39 [0.02, 9.15]
16.4 Maternal urinary tract infection 1 48 Risk Ratio (M‐H, Fixed, 95% CI) Not estimable